Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLP-1001 in Heart Failure with Fluid Overload
NCT01736735Phase 2Unknown
- Sponsor
- Sorbent Therapeutics
- Start
- Jan 2013
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of CLP-1001 in heart failure (HF), sponsored by Sorbent Therapeutics. Status: unknown.
02
Drugs
CLP-1001
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT01736735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01736735.